Blog
Ketamine Therapy: A Growing Record of Safety — and Unexpected Seizure Benefits
A recent large-scale, study has highlighted an important side benefit of ketamine that could impact how we counsel patients here in Philly — including those with PTSD, depression, or comorbid seizure disorders.
Could Folate Receptor Autoantibodies Be the Missing Link in PANS/PANDAS?
New research offers a promising new lead in how to treat children affected with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) and/or PANDAS.
Why the FDA Rejected MDMA Therapy for PTSD—and What It Means for the Future of Psychedelic Medicine
We are learning more and more about the effects of MDMA to treat PTSD. Here we learn more about the FDA’s ruling and what this means for patients looking for innovative treatments.
Quetiapine vs. Lithium: Which Augmentation Works Better for Treatment-Resistant Depression?
When depression becomes treatment-resistant, doctors look at other options to augment the treatment for better results. In here, we compare two of the most common options — Seroquel (quetiapine) and lithium.
Naltrexone-Bupropion for Weight Loss: What the Latest Research Tells Us
Learn how naltrexone-bupropion helps with weight loss, depression, and food cravings. Discover safety data and who benefits most.
Prenatal Acetaminophen Exposure and Risk of ADHD in Children: New Research Calls for Caution
New study links prenatal acetaminophen exposure to increased ADHD risk in children, especially girls. Dr. Danish breaks down the findings and implications.
Tranylcypromine: A Powerful and Underrated Option for Treatment-Resistant Depression
Dr. Danish tells us about the game changing drug, tranylcypromine (Parnate), that may help patients struggling with treatment-resistant depression (TRD) finally find relief.